Xconomy

NOVEMBER 13, 2019

Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Debuting in COI (which stands for “community of innovation”). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Avalon 73

Avalon San Diego Incubator Invest 73

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JULY 17, 2014

The latest venture capital totals from the PricewaterhouseCoopers/National Venture Capital Association''s MoneyTree Report was released this evening, tallying up $761.12M in investments in Q2 of 2014 in Southern California, up from Q2 of 2013, when $616.83M was invested in the region. Nationally, there was $13.0

Southern California 240

Southern California El Segundo Culver City Orange County 240

socalTECH

JULY 16, 2013

In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. The fund has not yet announced local investments, but has been actively talking to companies fitting its investment profile. READ MORE>>.

Capital 174

Capital Southern California Avalon SoCalTech 174

Xconomy

AUGUST 17, 2016

Pharmstandard International, the Luxembourg-based investment arm of the Russian pharmaceutical giant Pharmstandard (and a first-time investor in Avelas), led the round. It was joined by two other new backers, Ervington Investments and Alexandria Venture Investments, and previous investors WuXi Healthcare Ventures, Bregua Corp.,

Avalon 40

Avalon San Diego Study Invest 40

socalTECH

JANUARY 19, 2012

The latest numbers from the PricewaterhouseCoopers/National Venture capital Association MoneyTree survey, which is based on data from Thomson Reuters, tallies $738.34M invested in Southern California in Q4 of 2011. The amount is up from $528.0M raised in Q4 of 2010, and up from the $652M invested in the region last quarter.

Southern California 157

Southern California Orange County San Diego GRP Partners 157